SUNPHARMA's weekly return of 1.75% outperformed peers DRREDDY and HINDUNILVR, but underperformed DIVISLAB. The stock's volatility of 11.8% was relatively moderate, indicating a stable performance. With a Sharpe Ratio of 0.59, SUNPHARMA's return was decent considering the risk taken. The Max Drawdown of -0.62% suggests that the stock was not overly risky this week.

[Volatility: 11.8%]